Top House Dem Buys Stock in Pharma Companies and Defense Contractors


The Build Back Better Act is in limbo in the U.S. House, with Democratic leaders delaying a vote on the bill on Friday, casting doubt over the fate of provisions added back into the plan that would curb prescription drug costs. In a dramatic late-night decision, Speaker Pelosi allowed a vote on the bipartisan infrastructure […]

From Sludge
On November 9, 2021